FDA Inspection 1192016 — Instylla, Inc.
The FDA completed an inspection of Instylla, Inc. on November 16, 2022 in Bedford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 16, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Bedford, MA (United States)